Literature DB >> 22016411

MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

M Essig1, N Anzalone, S E Combs, À Dörfler, S-K Lee, P Picozzi, A Rovira, M Weller, M Law.   

Abstract

MR imaging is the preferred technique for the diagnosis, treatment planning, and monitoring of patients with neoplastic CNS lesions. Conventional MR imaging, with gadolinium-based contrast enhancement, is increasingly combined with advanced, functional MR imaging techniques to offer morphologic, metabolic, and physiologic information. This article provides updated recommendations to neuroradiologists, neuro-oncologists, neurosurgeons, and radiation oncologists on the practical applications of MR imaging of neoplastic CNS lesions in adults, with particular focus on gliomas, based on a review of the clinical trial evidence and personal experiences shared at a recent international meeting of experts in neuroradiology, neuro-oncology, neurosurgery, and radio-oncology.

Entities:  

Mesh:

Year:  2011        PMID: 22016411      PMCID: PMC7968800          DOI: 10.3174/ajnr.A2640

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  114 in total

1.  Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.

Authors:  Kenneth R Maravilla; Joseph A Maldjian; Ilona M Schmalfuss; Matthew J Kuhn; Brian C Bowen; Franz J Wippold; Val M Runge; Michael V Knopp; Stephane Kremer; Leo J Wolansky; Nicoletta Anzalone; Marco Essig; Lars Gustafsson
Journal:  Radiology       Date:  2006-06-26       Impact factor: 11.105

2.  Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma.

Authors:  A Jackson; G C Jayson; K L Li; X P Zhu; D R Checkley; J J L Tessier; J C Waterton
Journal:  Br J Radiol       Date:  2003-03       Impact factor: 3.039

3.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

4.  Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Authors:  Marc-André Weber; Marcus Henze; Jochen Tüttenberg; Bram Stieltjes; Marco Meissner; Fabian Zimmer; Iris Burkholder; Alexander Kroll; Stephanie E Combs; Marlies Vogt-Schaden; Frederik L Giesel; Saida Zoubaa; Uwe Haberkorn; Hans-Ulrich Kauczor; Marco Essig
Journal:  Invest Radiol       Date:  2010-12       Impact factor: 6.016

Review 5.  Diffusion tensor imaging in cerebral tumor diagnosis and therapy.

Authors:  Aaron S Field; Andrew L Alexander
Journal:  Top Magn Reson Imaging       Date:  2004-10

Review 6.  Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Authors:  Dieta Brandsma; Lukas Stalpers; Walter Taal; Peter Sminia; Martin J van den Bent
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

7.  Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.

Authors:  S Cha; L Yang; G Johnson; A Lai; M-H Chen; T Tihan; M Wendland; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

8.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

Review 9.  Clinical applications of PET in brain tumors.

Authors:  Wei Chen
Journal:  J Nucl Med       Date:  2007-08-17       Impact factor: 10.057

10.  The effectiveness of implementing a care pathway for femoral neck fracture in older people: a prospective controlled before and after study.

Authors:  Helen C Roberts; Ruth M Pickering; Elizabeth Onslow; Mike Clancy; Jackie Powell; Alison Roberts; Kerry Hughes; Diane Coulson; Jane Bray
Journal:  Age Ageing       Date:  2004-03       Impact factor: 10.668

View more
  32 in total

Review 1.  Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

Review 2.  MR-guided radiation therapy: transformative technology and its role in the central nervous system.

Authors:  Yue Cao; Chia-Lin Tseng; James M Balter; Feifei Teng; Hemant A Parmar; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Additive value of 320-section low-dose dynamic volume CT in relation to 3-T MRI for the preoperative evaluation of brain tumors.

Authors:  Eri Hayashida; Toshinori Hirai; Hideo Nakamura; Masafumi Kidoh; Minako Azuma; Yasuhiko Iryo; Mika Kitajima; Seitaro Oda; Daisuke Utsunomiya; Takeshi Nakaura; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2016-08-26       Impact factor: 2.374

4.  Preradiotherapy MR Imaging: A Prospective Pilot Study of the Usefulness of Performing an MR Examination Shortly before Radiation Therapy in Patients with Glioblastoma.

Authors:  C Majós; M Cos; S Castañer; A Pons; M Gil; A Fernández-Coello; M Macià; J Bruna; C Aguilera
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-08       Impact factor: 3.825

5.  Diagnostic performance of apparent diffusion coefficient parameters for glioma grading.

Authors:  Qun Wang; JiaShu Zhang; Xinghua Xu; XiaoLei Chen; BaiNan Xu
Journal:  J Neurooncol       Date:  2018-03-24       Impact factor: 4.130

Review 6.  Perfusion MRI: the five most frequently asked technical questions.

Authors:  Marco Essig; Mark S Shiroishi; Thanh Binh Nguyen; Marc Saake; James M Provenzale; David Enterline; Nicoletta Anzalone; Arnd Dörfler; Alex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

7.  Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield.

Authors:  Or Cohen-Inbar; Zhiyuan Xu; Blair Dodson; Tanvir Rizvi; Christopher R Durst; Sugoto Mukherjee; Jason P Sheehan
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

8.  Assessment of diffusion tensor imaging metrics in differentiating low-grade from high-grade gliomas.

Authors:  Lamiaa El-Serougy; Ahmed Abdel Khalek Abdel Razek; Amani Ezzat; Hany Eldawoody; Ahmad El-Morsy
Journal:  Neuroradiol J       Date:  2016-08-25

9.  Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas.

Authors:  Antonio Di Ieva; Sabine Göd; Günther Grabner; Fabio Grizzi; Camillo Sherif; Christian Matula; Manfred Tschabitscher; Siegfrid Trattnig
Journal:  Neuroradiology       Date:  2012-08-18       Impact factor: 2.804

10.  Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?

Authors:  Andrea Horváth; Gábor Perlaki; Arnold Tóth; Gergely Orsi; Szilvia Nagy; Tamás Dóczi; Zsolt Horváth; Péter Bogner
Journal:  J Neurooncol       Date:  2015-11-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.